Enzyme-Linked Immunosorbent Assay (ELISA)
Detection and quantification of antibodies directed against adalimumab in human serum. Trough level quantitation for evaluation of patients with loss of response to adalimumab.
Adalimumab: limit of quantitation is 0.8 mcg/mL. Optimal therapeutic ranges are disease specific.
Adalimumab Antibody: <14.0 AU/mL
* Reference ranges may change over time. Please refer to the original patient report when evaluating results.
6 - 8 days
- Adalimumab Concentration and Anti-Adalimumab Antibody
If the result is 5.0 mcg/mL or less, the adalimumab antibody test will be performed at an additional charge. By ordering this test the clinician acknowledges that additional reflex testing will be performed and billed at a separate additional charge if indicated. Test sent to Mayo Medical Laboratories.